Study in HCV-Infected Patients to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of JNJ-47910382

Summary

The purpose of this study is to determine the safety, tolerability, pharmacokinetics (what the body does to the medication) and antiviral activity of JNJ-47910382 when administered in different dosing regimens in Caucasian genotype-1 chronic HCV-infected patients.

Timeline

Start

2012-08

Primary completion

2013-06

Completion

2013-06

Outcome

Outcome not reported

Stopped: “Because of many competing trials using the same mechanism of action, but being further advanced in development”

Drugs

Indications